Type 2 diabetes: strategy for patient management excepting complications.

被引：0
|
作者：
Charbonnel, B [1 ]
机构：
[1] Hotel Dieu, F-44093 Nantes, France
来源：
DIABETES & METABOLISM | 2000年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：232 / 243
页数：12
相关论文
共 50 条
  • [1] Microalbuminuria in the diabetes of type 2/frequency and correlation with degenerative complications.
    Khiat, A
    Khalfa, PS
    DIABETES & METABOLISM, 2006, 32 : S54 - S54
  • [2] Management strategy for type 2 diabetes patients (excluding care for complications)
    ANNALES D ENDOCRINOLOGIE, 2000, 61 (03) : 275 - 283
  • [3] Dynamic videocapillaroscopy in Type 2 diabetes mellitus with and without microvascular complications.
    Fernandes, TJ
    Halfoun, VRC
    Pires, MLE
    Vangelotti, AM
    Cardozo, MG
    DIABETOLOGIA, 2003, 46 : A413 - A413
  • [4] Genetics of diabetes complications.
    Bowden D.W.
    Current Diabetes Reports, 2002, 2 (2) : 191 - 200
  • [5] Increased fibrinogen synthesis in type 2 diabetes mellitus without vascular complications.
    Barazzoni, R
    Zanetti, M
    Davanzo, G
    Vettore, M
    Kiwanuka, E
    Carraro, P
    Tiengo, A
    Tessari, P
    DIABETOLOGIA, 1997, 40 : 1597 - 1597
  • [6] Follow-up of type 2 diabetes mellitus patients, excluding complications.
    不详
    SEMAINE DES HOPITAUX, 1999, 75 (15-16): : 447 - 453
  • [7] The uncomplicated guide to diabetes complications.
    Kelly, K
    LIBRARY JOURNAL, 1998, 123 (13) : 123 - 123
  • [8] Pharmacological Management of Type 2 Diabetes Complications
    Doumas, Michael
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Athyros, Vasilios G.
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (02) : 101 - 103
  • [9] Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
    Aguilar-Salinas, Carlos A.
    Mehta, Roopa
    Rojas, Rosalba
    Gomez-Perez, Francisco J.
    Olaiz, Gustavo
    Rull, Juan A.
    CURRENT DIABETES REVIEWS, 2005, 1 (02) : 145 - 158
  • [10] Use of insulin in Type 2 patients with microvascular complications.
    Gfrerer, RJ
    Rakovac, I
    Habacher, W
    Seereiner, S
    Beck, P
    Jeitler, K
    Moser, R
    Risse, A
    Jecht, M
    Mrak, P
    Pieber, TR
    DIABETOLOGIA, 2003, 46 : A428 - A429
12345